Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/36th-international-conference-pharmacoepidemiology-and	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management	Publications and Presentations	09/16/2020	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Publications and Presentations 09/16/2020
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-individuals-gout-using-urate-lowering-therapy-ult-and	Counts of Individuals with Gout Using Urate-Lowering Therapy (ULT) and Switching between ULT Products: A Descriptive Analysis	Modular Programs	11/12/2020	Counts of Individuals with Gout Using Urate-Lowering Therapy (ULT) and Switching between ULT Products: A Descriptive Analysis Modular Programs 11/12/2020
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-mothers-mother-infant-linkage-table	Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis	Modular Programs	03/11/2021	Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Modular Programs 03/11/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/dayvigo-lemborexant	Assessment of ARIA Sufficiency: Dayvigo (lemborexant)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Dayvigo (lemborexant) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/gimoti-metoclopramide-nasal-spray	Assessment of ARIA Sufficiency: Gimoti (metoclopramide nasal spray)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Gimoti (metoclopramide nasal spray) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/leqvio-inclisiran	Assessment of ARIA Sufficiency: Leqvio (inclisiran)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Leqvio (inclisiran) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/nexletol-bempedoic-acid	Assessment of ARIA Sufficiency: Nexletol (bempedoic acid)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Nexletol (bempedoic acid) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/nexlizet-bempedoic-acid-and-ezetimibe	Assessment of ARIA Sufficiency: Nexlizet (bempedoic acid and ezetimibe)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Nexlizet (bempedoic acid and ezetimibe) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/opzelura-ruxolitinib	Assessment of ARIA Sufficiency: Opzelura (ruxolitinib)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Opzelura (ruxolitinib) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/qulipta-atogepant	Assessment of ARIA Sufficiency: Qulipta (atogepant)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Qulipta (atogepant) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/patterns-insulin-product-use-and-billing-codes-descriptive	Patterns in Insulin Product Use and Billing Codes: A Descriptive Analysis	Modular Programs	04/16/2021	Patterns in Insulin Product Use and Billing Codes: A Descriptive Analysis Modular Programs 04/16/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/treescan-pregnancy	TreeScan in Pregnancy	Methods, Data, & Tools	07/14/2021	TreeScan in Pregnancy Methods, Data, & Tools 07/14/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/37th-international-conference-pharmacoepidemiology-and	37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management	Publications and Presentations	08/23/2021	37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Publications and Presentations 08/23/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs	Methods, Data, & Tools	09/24/2021	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools 09/24/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/natural-history-coagulopathy-covid-19-0	Natural History of Coagulopathy in COVID-19	Publications and Presentations	10/06/2021	Natural History of Coagulopathy in COVID-19 Publications and Presentations 10/06/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-multiple-sclerosis-drugs-among-pregnant-women-live-birth	Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive Analysis	Assessments	10/20/2021	Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive Analysis Assessments 10/20/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-community-building-and-outreach-center	2022 Sentinel Community Building and Outreach Center Webinar Series	Sentinel Initiative Events	11/23/2021	2022 Sentinel Community Building and Outreach Center Webinar Series Sentinel Initiative Events 11/23/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-innovation-and-methods-seminar-series	2022 Sentinel Innovation and Methods Seminar Series	Sentinel Initiative Events	01/01/2022	2022 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events 01/01/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/utility-fertility-procedures-and-prenatal-tests-estimate-0	Utility of Fertility Procedures and Prenatal Tests to Estimate Gestational Age for Live-births and Stillbirths in Electronic Health Plan Databases	Publications and Presentations	02/05/2022	Utility of Fertility Procedures and Prenatal Tests to Estimate Gestational Age for Live-births and Stillbirths in Electronic Health Plan Databases Publications and Presentations 02/05/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/systemic-corticosteroid-use-covid-19-us-outpatient-settings	Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021	Publications and Presentations	04/08/2022	Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021 Publications and Presentations 04/08/2022
https://www.sentinelinitiative.org/methods-data-tools/software-packages-toolkits/sentinel-views	Sentinel Views	Methods, Data, & Tools	04/22/2022	Sentinel Views Methods, Data, & Tools 04/22/2022
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/can-we-train-machine-learning-methods-outperform-high	Can We Train Machine Learning Methods to Outperform the High-Dimensional Propensity Score Algorithm?	Sentinel Initiative Events	05/11/2022	Can We Train Machine Learning Methods to Outperform the High-Dimensional Propensity Score Algorithm? Sentinel Initiative Events 05/11/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outpatient-corticosteroid-use-patients-covid-19-updated	Outpatient Corticosteroid Use in Patients With COVID-19: An Updated Descriptive Analysis	Analyses	06/02/2022	Outpatient Corticosteroid Use in Patients With COVID-19: An Updated Descriptive Analysis Analyses 06/02/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/bamlanivimab-bamlanivimab-and-etesevimab-and-casirivimab	Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis	Analyses	06/14/2022	Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis Analyses 06/14/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/count-and-duration-follow-new-onset-cancer-updated	Count and Duration of Follow up of New-Onset Cancer: An Updated Descriptive Analysis	Analyses	06/23/2022	Count and Duration of Follow up of New-Onset Cancer: An Updated Descriptive Analysis Analyses 06/23/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-monoclonal-antibodies-mabs-under-emergency-use	Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis	Analyses	06/24/2022	Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis Analyses 06/24/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/surveillance-adverse-infant-outcomes-following-maternal	Surveillance of Adverse Infant Outcomes Following Maternal Medication Use During Pregnancy Using Tree-Based Scan Statistics	Publications and Presentations	06/28/2022	Surveillance of Adverse Infant Outcomes Following Maternal Medication Use During Pregnancy Using Tree-Based Scan Statistics Publications and Presentations 06/28/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-infants-mother-infant-linkage-table	Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis	Analyses	06/30/2022	Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Analyses 06/30/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-sodium-glucose-co-transporter-2-sglt-2-inhibitor	Utilization of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitor Drugs: A Descriptive Analysis	Analyses	07/11/2022	Utilization of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitor Drugs: A Descriptive Analysis Analyses 07/11/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/hospitalization-and-anaphylaxis-following-monoclonal	Hospitalization and Anaphylaxis Following Monoclonal Antibodies (mAb) Use in Patients with COVID-19: A Descriptive Analysis	Analyses	07/14/2022	Hospitalization and Anaphylaxis Following Monoclonal Antibodies (mAb) Use in Patients with COVID-19: A Descriptive Analysis Analyses 07/14/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/new-onset-cancer-cases-fda-s-sentinel-system-large	New-Onset Cancer Cases in FDA’s Sentinel System: A Large Distributed System of US Electronic Healthcare Data	Publications and Presentations	07/15/2022	New-Onset Cancer Cases in FDA’s Sentinel System: A Large Distributed System of US Electronic Healthcare Data Publications and Presentations 07/15/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-sodium-glucose-co	Counts and Characteristics of Individuals with Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitor Use: A Descriptive Analysis	Analyses	07/15/2022	Counts and Characteristics of Individuals with Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitor Use: A Descriptive Analysis Analyses 07/15/2022
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/zimhi-naloxone	Assessment of ARIA Sufficiency: Zimhi (naloxone)	Sufficiency Assessments	07/20/2022	Assessment of ARIA Sufficiency: Zimhi (naloxone) Sufficiency Assessments 07/20/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/novel-methods-pregnancy-drug-safety-surveillance-fda	Novel Methods for Pregnancy Drug Safety Surveillance in the FDA Sentinel System	Publications and Presentations	07/24/2022	Novel Methods for Pregnancy Drug Safety Surveillance in the FDA Sentinel System Publications and Presentations 07/24/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/cohort-study-assess-risk-cutaneous-small-vessel-vasculitis	A Cohort Study to Assess Risk of Cutaneous Small Vessel Vasculitis Among Users of Different Oral Anticoagulants	Publications and Presentations	07/31/2022	A Cohort Study to Assess Risk of Cutaneous Small Vessel Vasculitis Among Users of Different Oral Anticoagulants Publications and Presentations 07/31/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-obesity-drugs-descriptive-analysis	Utilization of Obesity Drugs: A Descriptive Analysis	Analyses	08/05/2022	Utilization of Obesity Drugs: A Descriptive Analysis Analyses 08/05/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/using-treescan-signal-identification-approach-screen-adverse	Using TreeScan as a Signal Identification Approach to Screen for Adverse Maternal Outcomes of Medication Use in Pregnancy	Publications and Presentations	08/09/2022	Using TreeScan as a Signal Identification Approach to Screen for Adverse Maternal Outcomes of Medication Use in Pregnancy Publications and Presentations 08/09/2022
https://www.sentinelinitiative.org/studies/drugs/women-heart-failure	Women with Heart Failure & Pregnancy	Studies	08/10/2022	Women with Heart Failure & Pregnancy Studies 08/10/2022
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/advancing-use-real-world-evidence-health-technology	Advancing the Use of Real-World Evidence for Health Technology Assessment – The NICE Real-World Evidence Framework	Sentinel Initiative Events	08/11/2022	Advancing the Use of Real-World Evidence for Health Technology Assessment – The NICE Real-World Evidence Framework Sentinel Initiative Events 08/11/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/association-covid-19-vs-influenza-risk-arterial-and-venous	Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients	Publications and Presentations	08/16/2022	Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients Publications and Presentations 08/16/2022